Purchase Order 75N94023P00707
Award Date 8/17/23
Potential Completion Date 8/16/24
Potential Value $14K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Bethesda, MD 20892, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Department of Health and Human Services' National Institutes of Health's National Institute of Child Health and Human Development awarded a $14,141.84 purchase order to Genscript USA Inc. for "OTHER FUNCTIONS - CUSTOMIZED GENE SYNTHESES" to be performed in Bethesda, Maryland between September 8-16, 2016. As a firm fixed price contract for customized gene synthesis services, Genscript will deliver specified genetic material to the NIH organization to support its biomedical...
- The National Institutes of Health's National Institute of Child Health and Human Development awarded a $24,500 firm fixed price blanket purchase agreement call contract to Genscript USA Inc. of Piscataway, New Jersey. Under this contract, Genscript will provide custom gene synthesis services to NICHD in support of the Institute's research efforts. The contract has a period of performance of one year, from June 2023 through June 2024. It contains a total small business set-aside designation. No...
- The Department of Health and Human Services' National Institutes of Health's National Institute of Child Health and Human Development awarded a $10,000 purchase order to Genscript USA Inc. to deliver a 2000 base pair gene synthesis in a PUC57 vector with 4 micrograms of the synthesized gene. The place of performance for this firm fixed price contract is in Bethesda, Maryland. This purchase supports the NIH's mission to conduct and fund medical research that could improve public health, likely...
- The National Institute of Child Health and Human Development (NICHD) awarded a $20,000 firm fixed price Blanket Purchase Agreement (BPA) call to Genscript USA Inc. for customized gene synthesis services. This contract, issued on July 1, 2014, with an ultimate completion date of June 30, 2015, represents a non-set-aside award to the Piscataway, New Jersey-based biotechnology firm. The work will be performed at Genscript's facility in Piscataway, NJ 08854. Genscript USA Inc. is a specialized...
- This firm fixed-price purchase order was awarded by the National Institute of Child Health and Human Development (NICHD), part of the National Institutes of Health (NIH), to GenScript USA Inc., a biotechnology company based in Piscataway, New Jersey. The $65,963.22 contract is for gene synthesis and related services to support NICHD's research on how transcription factors regulate gene expression and chromatin structure. The award stems from a sole-source special notice solicitation, as NICHD...
- This is a firm fixed-price purchase order awarded by the National Institute of Child Health and Human Development (NICHD), which is part of the Department of Health and Human Services (HHS). The contract was awarded to Genscript USA Inc., a small business biotechnology company based in Piscataway, New Jersey, for $11,434.95. The contract has an ultimate completion date of July 30, 2025. Genscript specializes in gene synthesis, gene editing, custom protein and antibody production, and other...
- The National Institute of Child Health and Human Development (NICHD) awarded a Blanket Purchase Agreement (BPA) call order to GenScript USA Inc. valued at $24,500 on July 20, 2018, with an ultimate completion date of July 19, 2019. This firm fixed-price contract, which utilized no set-aside designation, represents a task order against an existing BPA vehicle and is to be performed in Bethesda, Maryland. GenScript USA Inc., a biotechnology company headquartered in Piscataway, New Jersey,...
- GenScript USA Inc. was awarded an $8,500 firm fixed price BPA call by the National Institute of Child Health and Human Development (NICHD) on September 24, 2014, with an ultimate completion date of June 30, 2015. The contract was executed without a set-aside designation and represents a task order against an existing blanket purchase agreement. Performance is scheduled to take place in Bethesda, Maryland. As a biotechnology company specializing in advanced molecular biology services, GenScript...
- This is a $14,500 firm fixed-price purchase order awarded by the National Institute of Child Health and Human Development (NICHD), a civilian agency within the Department of Health and Human Services (HHS), to Genscript USA Inc., a biotechnology company in Piscataway, New Jersey. The contract is for NICHD laboratory services and does not have a set-aside designation. Genscript is a provider of a wide range of molecular biology products and services to federal agencies, including gene...
- The Department of Health and Human Services' National Institutes of Health's National Institute of Child Health and Human Development awarded a $6,492.65 firm fixed price purchase order to Genscript USA Inc. of Piscataway, New Jersey. Under the contract, Genscript will provide anti-acetylated K421 to the NIH/NICHD between May 11, 2018 and August 31, 2018 to support the agency's biomedical research efforts. No additional details were provided regarding the original solicitation, use of...